NIP
ASND icon

Nicholas Investment Partners’s Ascendis Pharma A/S ASND Stock Holding History

Nicholas Investment Partners’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
38,160
+11,293
+42% +$2.64M 0.57% 63
2026
Q1 		$6.15M Buy
26,867
+20,602
+329% +$4.62M 0.44% 81
2025
Q4 		$1.34M Buy
6,265
+1,955
+45% +$404K 0.1% 167
2025
Q3 		$857K Buy
4,310
+1,673
+63% +$312K 0.07% 186
2025
Q2 		$455K Buy
+2,637
New +$430K 0.04% 203
2024
Q4 		– Sell
-8,474
Closed -$1.27M – 226
2024
Q3 		$1.27M Sell
8,474
-14,742
-63% -$1.99M 0.12% 177
2024
Q2 		$3.17M Buy
23,216
+5,232
+29% +$712K 0.33% 115
2024
Q1 		$2.72M Buy
17,984
+13,717
+321% +$1.96M 0.28% 129
2023
Q4 		$537K Sell
4,267
-166,342
-97% -$16.6M 0.06% 172
2023
Q3 		$16M Hold
170,609
– – 1.19% 29
2023
Q2 		$15.2M Sell
170,609
-80,778
-32% -$7.03M 1.04% 33
2023
Q1 		$27M Buy
251,387
+85,450
+51% +$9.78M 2.05% 12
2022
Q4 		$20.3M Buy
165,937
+28,383
+21% +$3.3M 1.78% 10
2022
Q3 		$14.2M Buy
137,554
+30,623
+29% +$2.9M 1.32% 23
2022
Q2 		$9.94M Sell
106,931
-80,470
-43% -$7.58M 0.94% 36
2022
Q1 		$22M Buy
187,401
+75,279
+67% +$8.72M 1.56% 12
2021
Q4 		$15.1M Buy
112,122
+84,988
+313% +$12.6M 0.95% 29
2021
Q3 		$4.33M Buy
+27,134
New +$3.71M 0.32% 110
2019
Q2 		– Sell
-4,643
Closed -$546K – 210
2019
Q1 		$546K Buy
+4,643
New +$407K 0.05% 205

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Nicholas Investment Partners's ASND Position: Q2 2026 in Review

Nicholas Investment Partners increased its Ascendis Pharma A/S (ASND) stake by 42% in Q2 2026, buying an estimated $2.64M and bringing the position to 38,160 shares worth $10.2M. The position accounts for 0.57% of the portfolio, ranked #63.

Nicholas Investment Partners first reported a position in ASND in Q1 2019 and has held it in 19 quarters since. The position peaked at $27M in Q1 2023. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.

  • Nicholas Investment Partners held 38,160 shares of Ascendis Pharma A/S worth $10.2M as of Q2 2026.
  • Nicholas Investment Partners bought 11,293 Ascendis Pharma A/S shares in Q2 2026, an estimated $2.64M.
  • Ascendis Pharma A/S made up 0.57% of Nicholas Investment Partners's portfolio in Q2 2026, its #63 holding.
  • Nicholas Investment Partners first reported a position in Ascendis Pharma A/S in Q1 2019 and has held it in 19 quarters since.
  • Nicholas Investment Partners's Ascendis Pharma A/S position peaked at $27M in Q1 2023.
  • 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.

Based on Nicholas Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.